Cerep SA (ALCER) - Financial and Strategic SWOT Analysis Review

Date: November 7, 2012
Pages: 31
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: CEC865E35FCEN
Leaflet:

Download PDF Leaflet

Cerep SA (ALCER) - Financial and Strategic SWOT Analysis Review
Summary

Cerep SA (Cerep) focuses on offering in vitro and in vivo solutions. The solutions allow early discovery of encouraging drug candidates and terminating compounds likely to fail in development. The company's services comprises compound management, high-throughput screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling and in vivo PK. It also offers assay development, profile design and data interpretation services. Cerep operates along with its subsidiaries in Europe, Asia, North America and Australia. It also manages laboratories in France, China and the US. The company is headquartered in Paris, France.

The company seeks to reorganize its operations through a restructuring program aimed at improving its profitability.

Cerep SA Key Recent Developments

Jun 13, 2011: Cerep To Build Epigenetics Screening And Profiling Laboratory In Toronto, Canada

This comprehensive SWOT profile of Cerep SA provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY

Cerep SA - Key Facts
Cerep SA - Key Employees
Cerep SA - Key Employee Biographies
Cerep SA - Major Products and Services
Cerep SA - History
Cerep SA - Company Statement
Cerep SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Cerep SA - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Cerep SA - Business Description
Cerep SA - SWOT Analysis
SWOT Analysis - Overview
Cerep SA - Strengths
Strength - In-house research expertise
Strength - Broad Portfolio of Services
Strength - Extensive Geographical Reach
Cerep SA - Weaknesses
Weakness - Declining Revenue
Cerep SA - Opportunities
Opportunity - Emerging Markets
Opportunity - Contract Research Outsourcing Market
Opportunity - Changing Demographics
Cerep SA - Threats
Threat - Competitive Pressures
Threat - Government Regulations
Threat - Uncertain R&D Outcomes
Cerep SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Cerep SA, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Cerep SA, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Cerep SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Cerep SA, Recent Developments
Jun 13, 2011: Cerep To Build Epigenetics Screening And Profiling Laboratory In Toronto, Canada

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Cerep SA, Key Facts
Cerep SA, Key Employees
Cerep SA, Key Employee Biographies
Cerep SA, Major Products and Services
Cerep SA, History
Cerep SA, Other Locations
Cerep SA, Subsidiaries
Cerep SA, Key Manufacturing Facilities
Cerep SA, Key Competitors
Cerep SA, Ratios based on current share price
Cerep SA, Annual Ratios
Cerep SA, Interim Ratios
Cerep SA, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Cerep SA, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Cerep SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Cerep SA, Performance Chart (2006 - 2010)
Cerep SA, Ratio Charts
Cerep SA, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Cerep SA, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012

Ask Your Question

Cerep SA (ALCER) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: